Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1Phase 1/2 1

Status

Completed 8Unknown 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 43Squamous Cell Carcinoma of Head and Neck 12Rectal Neoplasms 12Colonic Neoplasms 11Neoplasm Metastasis 9Head and Neck Neoplasms 8Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Colorectal Cancer Metastatic 3Carcinoma, Non-Small-Cell Lung 3Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Squamous Cell 2mCRC 1Stomach Neoplasms 1Skin Neoplasms 1Recurrence 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Liver Metastasis Colon Cancer 1Incurable Colorectal Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1

Interventions

Cisplatin 27Paclitaxel 18Radiotherapy 17Fluorouracil 13Drug Therapy 12camrelizumab 10toripalimab 8Carboplatin 8Radiotherapy, Intensity-Modulated 6Radiation 6Capecitabine 6sintilimab 5S 1 (combination) 5Esophagectomy 5tislelizumab 4nimotuzumab 4apatinib 4anlotinib 4Irinotecan 4Cetuximab 4Afatinib 4pembrolizumab 3durvalumab 3Vinorelbine 3Positron Emission Tomography Computed Tomography 3Oxaliplatin 3Nivolumab 3Immune Checkpoint Inhibitors 3Docetaxel 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Esophageal Squamous Cell Carcinoma × Cetuximab × Clear all
NCT02123381 2020-03-17

Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherapy in Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Sichuan Cancer Hospital and Research Institute

Phase 2 Unknown
100 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasms

NCT03126708 2018-01-04

Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Peking University

Phase 2 Unknown
150 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00425425 2014-05-01

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Technical University of Munich

Phase 1/2 Unknown
43 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡